About
Science
- (Z)-endoxifen
- Clinical Trials
Breast Cancer
- Programs
- Patient Resources
Duchenne
Expanded Access
Investors

About
Science
- (Z)-endoxifen
- Clinical Trials
Breast Cancer
- Programs
- Patient Resources
Duchenne
Expanded Access
Investors

Leadership

Management Team

Steven C. Quay
MD, PHD

Chairman of the Board and Chief Executive Officer

Mark Daniel

Chief Financial Officer

Delly Behen

Senior Vice President, Business Operations

Janet R. Rea, MSPH

Senior Vice President, Research & Development

Atossa Therapeutics is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.

COMPANY

About Us
Leadership
Programs
Breast Cancer
Contact Us

INVESTOR RELATIONS

Overview
Stock Info
News & Events
Financials & Filings
Corporate Governance
IR Resources

CONTACT

1 (206) 588-0256
info@atossainc.com
1448 NW Market St, Suite 500
Seattle, WA 98107

Copyright © 2025 Atossa Therapeutics, Inc. All Rights Reserved.

Privacy Policy | Legal | Terms of Use | Expanded Access Policy

For US residents only: this website does not intend to collect information from non-US residents. If you are a patient participating in a clinical trial, please do not send any personal information to Atossa. Please refer to your doctor.